Ligand validation:5JY3

BU1: 1,4-BUTANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5JY3_BU1_D_502	53%	57%	0.19	0.952	0.3	1.31	-	-	5	0	100%	1
5JY3_BU1_B_502	41%	70%	0.213	0.928	0.61	0.55	-	-	1	0	100%	1
4RAK_BU1_A_501	30%	84%	0.183	0.847	0.35	0.42	-	-	0	0	100%	1
4OP4_BU1_B_305	99%	89%	0.05	0.984	0.24	0.39	-	-	0	0	100%	1
4S27_BU1_A_707	98%	96%	0.057	0.983	0.13	0.21	-	-	0	0	100%	0.53
3CED_BU1_A_402	96%	81%	0.071	0.978	0.22	0.6	-	-	0	0	100%	1
4S28_BU1_A_706	95%	97%	0.077	0.982	0.19	0.14	-	-	0	0	100%	0.52
4S29_BU1_A_703	93%	94%	0.084	0.98	0.17	0.27	-	-	0	0	100%	0.5

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.